Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy

por Mehta, Amol, Awah, Chidiebere U., Sonabend, Adam M.
Publicado 2018

A regulatory SNP modifies cystic fibrosis by disrupting NFκB complex binding on FAS

por Awah, Chidiebere U, Hedtfeld, Silke, Tümmler, Burkhard, Stanke, Frauke
Publicado 2015

NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interaction

por Awah, Chidiebere U, Winter, Jan, Mazdoom, Claudiane M, Ogunwobi, Olorunseun O.
Publicado 2021

Destabilized 3’UTR elements therapeutically degrade ERBB2 mRNA in drug-resistant ERBB2+ cancer models

por Awah, Chidiebere U., Glemaud, Yana, Levine, Fayola, Yang, Kiseok, Ansary, Afrin, Dong, Fu, Ash, Leonard, Zhang, Junfei, Ogunwobi, Olorunseun O.
Publicado 2023

Ribosomal protein S11 influences glioma response to TOP2 poisons

por Awah, Chidiebere U, Chen, Li, Bansal, Mukesh, Mahajan, Aayushi, Winter, Jan, Lad, Meeki, Warnke, Louisa, Gonzalez-Buendia, Edgar, Park, Cheol, Daniel, Zhang, Feldstein, Eric, Yu, Dou, Zannikou, Markella, Balyasnikova, Irina V., Martuscello, Regina, Konerman, Silvana, Győrffy, Balázs, Burdett, Kirsten B, Scholtens, Denise M, Stupp, Roger, Ahmed, Atique, Hsu, Patrick, Sonabend, Adam M
Publicado 2020